We have a central joint laboratory at Kent State University and dozens of research and development teams working on nanotechnology and biopharmaceuticals.
We have a number of proprietary patented technology, a number of products by the United States FDA certification and through the mainland of China's national standard test report and production batch number.
We have invested in qualified pharmaceutical factories and GMP plants in Xiamen, Suzhou, Laos and Cambodia, China, specializing in the production of APIs and generics.
People Cambridge Holdings Doctor Group Co., Ltd. has hundreds of professional multi-point practitioners in China, engaged in Internet remote consultation and services.
Five independent R&D teams, each with a Ph.D. LED professional technical team, covering nano-drug delivery technology, biological enzymes, biological pharmaceuticals, targeted generics, protein and ribose research and other fields.